Tomáš Hanke, HIVR4P 2021: T cell Vaccines for HIV-1 Infection (Part 1)

It was a pleasure to speak with Tomáš Hanke (University of Oxford, Oxford, UK) to discuss his recent work in T cell responses in HIV to inform vaccine development.

His abstract entitled: ‘Refocusing T cell responses with therapeutic vaccination strategies’ (SY09.03) was presented at the HIVR4P Virtual Conference 2021, 04 February 2021.

Part 1 of our discussion can be viewed here.

Questions:

1. What are the aims of your research? (0:19)
2. How can vaccines exploit vulnerability of the HIV virus? (0:50)
3. Could you tell us a little about the design of the vaccines you have developed? (1:40)
4. What is the current status of development of these vaccines? (2:52)
5. What further studies are planned? (4:10)

Disclosures: Tomáš Hanke is a QA coinventor on a patent protecting the use of the conserved mosaic vaccines.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Filmed in coverage of the HIVR4P Virtual Conference 2021.